Regulatory & Legal

Quantum firm Zapata adds industry veterans to its board, signaling a strategic shift in the quantum race from hardware supremacy to software application.

With its novel glaucoma drug QLS-111 entering Phase 3, Qlaris Bio brings in seasoned leader Fred Guerard to navigate the final trials and path to market.

With its CAR-T therapy achieving franchise profitability and treating 10,000 patients, Legend Biotech eyes overall profit and next-gen cancer treatments.

PowerBank Corp. secures millions in state funding to build a community solar farm on a former industrial site, promising lower energy bills for 875 homes.

Celebrating 80 years, Aveeno renews its foundational ties with Mayo Clinic, launching a new era of oat science research for compromised skin.

A landmark deal between Diverso and Dandelion Energy aims to make geothermal a standard utility in new homes, removing cost barriers for builders and buyers.

A new industry report claims mining for green minerals is low-emission, but reveals the real climate fight is decarbonizing steel and aluminum production.

Uranium Energy Corp reports a strong quarter with new mine completion, robust finances, and a strategic push to build a fully domestic nuclear fuel cycle.

A global consortium pioneers new drugs designed specifically for children, moving away from harsh adult treatments for aggressive pediatric cancers.

A new study reveals Canadians lost billions in wages waiting for care. This is the staggering personal and economic cost of the nation's healthcare queues.

K-pop sensation Kim Sejeong is the new face of REJURAN, a move merging celebrity appeal with advanced skin science to expand K-beauty's global reach.

OSE Immunotherapeutics confirms Marc Le Bozec as CEO, betting on his turnaround expertise to navigate market pressures and commercialize its key therapies.

A former space program manager is tackling a new frontier: teaching AI to everyone from academics to seniors, aiming to bridge a critical knowledge gap.

As private equity giant EIG sells its entire stake, Diversified Energy counters by repurchasing nearly half the shares in a bold vote of confidence.

With billions in government and private backing, USA Rare Earth hires legal, policy, and finance heavyweights to challenge China's grip on critical minerals.

A Texas hospital settled with an employee denied a religious exemption for a flu shot, highlighting a growing legal war over individual rights and public health.

The parent of Meineke and Maaco admits to 'material errors' in its financials, triggering a massive stock sell-off and a wave of investor lawsuits.

Neros Technologies delivers early on a key U.S. Army drone program and launches its next-gen, field-reconfigurable FPV system for modern warfighters.

An attorney's feature for International Women's Day sheds light on her dual role as counselor and the broader, changing landscape for women in the legal field.

Emalex Biosciences offers its investigational drug ecopipam to Tourette syndrome patients out of options, signaling a potential shift in treatment.